Mersana Therapeutics, Inc. Revenues
Mersana Therapeutics, Inc. reported Revenues of $4.19 million for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-14.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2018-08-14
- Mersana Therapeutics, Inc. revenues for the quarter ending 2018-06-30 was $4.19M, a 12.45% increase year-over-year.
- Mersana Therapeutics, Inc. revenues for the quarter ending 2018-03-31 was $3.06M, a 28.58% decline year-over-year.
- Mersana Therapeutics, Inc. revenues for the quarter ending 2017-12-31 was $3.26M, a 72.82% decline year-over-year.
- Mersana Therapeutics, Inc. revenues for the quarter ending 2017-09-30 was $6.27M, a 92.12% increase year-over-year.
- Mersana Therapeutics, Inc. revenues for fiscal 2017 was $17.55M, a 30.30% decline from fiscal 2016.
- Mersana Therapeutics, Inc. revenues for fiscal 2016 was $25.17M, a 142.99% increase from fiscal 2015.
- Mersana Therapeutics, Inc. revenues for fiscal 2015 was $10.36M.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2018-06-30 | $4.19M 10-Q · filed 2018-08-14 | $7.25M 10-Q · filed 2018-08-14 | $10.52M derived: sum of 3 quarters · filed 2018-08-14 | $16.78M derived: sum of 4 quarters · filed 2018-08-14 |
| 2018-03-31 | $3.06M 10-Q · filed 2018-05-15 | $6.33M derived: sum of 2 quarters · filed 2018-05-15 | $12.59M derived: sum of 3 quarters · filed 2018-05-15 | $16.32M derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-12-31 | $3.26M 10-K · filed 2018-03-28 | $9.53M derived: sum of 2 quarters · filed 2018-03-28 | $13.26M derived: sum of 3 quarters · filed 2018-08-14 | $17.55M 10-K · filed 2018-03-28 |
| 2017-09-30 | $6.27M 10-K · filed 2018-03-28 | $9.99M derived: sum of 2 quarters · filed 2018-08-14 | $14.28M 10-Q · filed 2017-11-13 | $26.28M derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-06-30 | $3.73M 10-Q · filed 2018-08-14 | $8.02M 10-Q · filed 2018-08-14 | $20.01M derived: sum of 3 quarters · filed 2018-08-14 | $23.28M derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $4.29M 10-Q · filed 2018-05-15 | $16.29M derived: sum of 2 quarters · filed 2018-05-15 | $19.55M derived: sum of 3 quarters · filed 2018-05-15 | $25.76M derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | $12.00M 10-K · filed 2018-03-28 | $15.26M derived: sum of 2 quarters · filed 2018-03-28 | $21.47M derived: sum of 3 quarters · filed 2018-03-28 | $25.17M 10-K · filed 2018-03-28 |
| 2016-09-30 | $3.26M 10-K · filed 2018-03-28 | $9.48M derived: sum of 2 quarters · filed 2018-03-28 | $13.18M 10-Q · filed 2017-11-13 | |
| 2016-06-30 | $6.21M 10-K · filed 2018-03-28 | $9.91M 10-Q · filed 2017-08-11 | ||
| 2016-03-31 | $3.70M 10-K · filed 2018-03-28 | |||
| 2015-12-31 | $10.36M 10-K · filed 2018-03-28 |